Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous Administration of Sabin-IPV and DTaP in Infants
NCT04054882Phase 4Completed
- Sponsor
- China National Biotec Group
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Sabin strain inactivated poliovirus vaccine, diphtheria + tetanus + acellular pertussis vaccine in poliomyelitis, diphtheria, Tetanus, pertussis, sponsored by China National Biotec Group. Started Aug 2019; status: completed.
02
Drugs
Sabin strain inactivated poliovirus vaccinediphtheria + tetanus + acellular pertussis vaccine
03
Conditions
poliomyelitisdiphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT04054882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04054882.